What ICD-10 code should be used for low testosterone (male hypogonadism)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ICD-10 Coding for Low Testosterone (Male Hypogonadism)

The appropriate ICD-10 code for low testosterone in males is E29.1 (Testicular hypogonadism) for primary hypogonadism or E23.0 (Hypopituitarism) for secondary hypogonadism, depending on the underlying etiology.

Diagnostic Requirements Before Coding

Before assigning an ICD-10 code for hypogonadism, you must confirm the diagnosis with:

  • Two separate fasting morning total testosterone measurements (8-10 AM) both < 300 ng/dL to establish biochemical hypogonadism, as single measurements are insufficient due to diurnal variation and assay variability 1, 2
  • Measurement of serum LH and FSH after confirming low testosterone to differentiate primary (elevated LH/FSH) from secondary (low or inappropriately normal LH/FSH) hypogonadism 2, 3
  • Presence of specific symptoms such as diminished libido or erectile dysfunction, as diagnosis requires both biochemical confirmation and appropriate clinical features 1, 2

Primary ICD-10 Codes

E29.1 - Testicular Hypogonadism (Primary/Hypergonadotropic Hypogonadism)

Use this code when:

  • Testosterone is low AND LH/FSH are elevated, indicating primary gonadal failure where the testes cannot respond to gonadotropin stimulation 2
  • The gonads are intrinsically damaged and unresponsive to hormonal manipulation 2
  • Common causes include Klinefelter syndrome, testicular trauma, chemotherapy, or radiation 2

E23.0 - Hypopituitarism (Secondary/Hypogonadotropic Hypogonadism)

Use this code when:

  • Testosterone is low AND LH/FSH are low or inappropriately normal, indicating impaired hypothalamic-pituitary function 2, 4
  • The gonads are structurally intact and capable of responding to gonadotropin stimulation 2
  • Common acquired causes include exogenous testosterone/anabolic steroids, opiates, cranial/pituitary radiation, hyperprolactinemia, type 2 diabetes, and obesity 2

Additional Relevant Codes

  • E29.8 - Other testicular dysfunction (for unspecified or atypical presentations)
  • E29.9 - Testicular dysfunction, unspecified (when etiology is unclear)
  • N46.0 - Azoospermia (if fertility impairment is documented)
  • E28.39 - Other primary ovarian failure (for female hypogonadism, not male)

Critical Coding Considerations

  • Never code based on symptoms alone without biochemical confirmation of low testosterone on two separate morning measurements 1, 2
  • Always obtain LH/FSH levels after confirming low testosterone, as the primary versus secondary distinction is essential for proper coding and directs treatment choice 2, 3
  • Do not code age-related testosterone decline as hypogonadism unless both biochemical criteria (testosterone < 300 ng/dL) and specific symptoms are present 1
  • Approximately 20-30% of men receiving testosterone therapy do not meet diagnostic criteria for hypogonadism, highlighting the importance of proper documentation before coding 1

Documentation Requirements for Coding

Your medical record should include:

  • Two morning testosterone values < 300 ng/dL measured between 8-10 AM on separate occasions 1, 2
  • LH and FSH levels to classify as primary or secondary 2, 3
  • Specific symptoms such as diminished libido, erectile dysfunction, or decreased spontaneous erections 1, 2
  • Exclusion of reversible causes such as medications (opiates, corticosteroids), obesity, metabolic syndrome, or chronic illness 2, 5

Common Pitfalls to Avoid

  • Do not code hypogonadism based on a single testosterone measurement, as this leads to misclassification 1, 2
  • Do not assign E29.1 or E23.0 without measuring LH/FSH, as the distinction between primary and secondary hypogonadism is critical for treatment and fertility counseling 2, 3
  • Do not code for nonspecific symptoms like fatigue, low energy, or mood changes alone, as these show minimal correlation with testosterone levels and do not improve reliably with therapy 1
  • Avoid coding in men with borderline testosterone (231-346 ng/dL) unless free testosterone is also measured and confirms true hypogonadism 1

References

Guideline

Testosterone Injection Treatment for Male Hypogonadism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Hypogonadism Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Male hypogonadism : an update on diagnosis and treatment.

Treatments in endocrinology, 2005

Research

Epidemiology, diagnosis, and treatment of male hypogonadotropic hypogonadism.

Journal of endocrinological investigation, 2009

Related Questions

What is the recommended treatment for a patient with a low testosterone level of 115 ng/dL?
In a 35‑year‑old male with low testosterone, low‑normal luteinizing hormone (LH), normal follicle‑stimulating hormone (FSH), fatigue, decreased libido, and 8 kg weight gain over six months, what is the likely diagnosis and appropriate evaluation and treatment?
In a 39-year-old man with low total testosterone, low free testosterone, low luteinizing hormone (LH), low follicle‑stimulating hormone (FSH), and normal prolactin, what is the next step in management?
In a 44-year-old male with low total testosterone and low‑normal free testosterone, is a referral to urology appropriate?
In a 41-year-old man with primary hypogonadism, low SHBG, elevated FSH and LH, normal prolactin, low estradiol, and low testosterone despite daily testosterone gel (Androgel), what workup and treatment are recommended?
My eosinophil count is 5.3 % (approximately 5.3 × 10⁹/L); what does this mild eosinophilia indicate and how should I evaluate and manage it?
What does a left‑ventricular end‑diastolic pressure (LVEDP) below 18 mm Hg indicate about cardiac filling pressures and clinical significance?
Can diltiazem be used in patients who are in shock?
Is labetalol oral (PO) dosing equivalent to intravenous (IV) dosing on a 1:1 milligram basis?
What is the recommended evaluation and work‑up for an adult patient presenting with decreased libido?
In an immunocompetent individual lacking varicella immunity, how effective is a single dose of live‑attenuated varicella vaccine at preventing clinical infection and severe disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.